Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174
AssigneeBoehringer Mannheim GmbH
InventorsWerner Lubitz, Michael P. Szostak
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Mannheim GmbH
InventorsWerner Lubitz, Michael P. Szostak
Estimating the term…
The invention concerns a carrier-bound recombinant protein obtainable by expression of a fusion protein gene in gram-negative bacteria which codes for at least one hydrophobic non-lytically active protein domain capable of membrane integration as well as the recombinant protein and of a gene which codes for a lytically active membrane protein from bacteriophages or a lytically active toxin release gene or lytically active partial sequences thereof and isolation of the carrier-bound recombinant protein from the culture broth. The recombinant protein is thereby firmly incorporated into the cell wall complex of gram-negative bacteria via a target sequence. Furthermore the invention concerns a recombinant DNA for the production of the protein, the production process as well as the use of carrier-bound recombinant proteins according to the present invention for immunization and as vaccines.
Immunogen comprising a non-lytic fusion protein bound to a portion of a gram negative bacterial cell membrane, wherein said fusion protein comprises:
Dependencies are inferred from the claim text.